tiprankstipranks
HCW Biologics announces results from ongoing Phase 1 trial of HCW9218
PremiumThe FlyHCW Biologics announces results from ongoing Phase 1 trial of HCW9218
6M ago
Investigator Sponsor of HCW Biologics’ Phase 1 Clinical Trial Presented Human Data Readout and Anti-Cancer Mechanism of Action of HCW9218 at 38th SITC Annual Meeting
PremiumPress Releases
Investigator Sponsor of HCW Biologics’ Phase 1 Clinical Trial Presented Human Data Readout and Anti-Cancer Mechanism of Action of HCW9218 at 38th SITC Annual Meeting
6M ago
Masonic Cancer Center, University of Minnesota to Present Data in Poster Presentation Human Data Readout for Phase 1 Study to Evaluate HCW9218 in Solid Tumors at SITC 38th Annual Meeting
PremiumPress Releases
Masonic Cancer Center, University of Minnesota to Present Data in Poster Presentation Human Data Readout for Phase 1 Study to Evaluate HCW9218 in Solid Tumors at SITC 38th Annual Meeting
6M ago
Is HCWB a Buy, Before Earnings?
PremiumPre-EarningsIs HCWB a Buy, Before Earnings?
9M ago
HCW Biologics granted U.S. patent for HCW9218
PremiumThe Fly
HCW Biologics granted U.S. patent for HCW9218
11M ago
HCW Biologics is Granted Third Fundamental Patent: U.S. Patent for Methods of Treating Age-Related Disorders
PremiumPress Releases
HCW Biologics is Granted Third Fundamental Patent: U.S. Patent for Methods of Treating Age-Related Disorders
11M ago
HCW Biologics Poster Presentation at AACR Annual Meeting 2023
PremiumPress ReleasesHCW Biologics Poster Presentation at AACR Annual Meeting 2023
1y ago
HCW Biologics announces new paper on treating aging-associated diseases
PremiumThe Fly
HCW Biologics announces new paper on treating aging-associated diseases
1y ago
A Novel Immunotherapeutic Approach to Treating Aging-Associated Diseases
PremiumPress Releases
A Novel Immunotherapeutic Approach to Treating Aging-Associated Diseases
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100